Trofinetide offers the first targeted treatment for Rett syndrome, with a new, convenient powdered formulation aimed at significantly reducing adverse effects. Rett syndrome is a severe ...

Switching to donidalorsen led to a 67.6% reduction in monthly HAE attack rates over 1 year, with consistent benefit across prior prophylactic therapies. Most patients achieved or maintained ...

Dr Dawson is chief of Adolescent Medicine Services, Carl R Darnall Army Medical Center Pediatric Clinic, Fort Hood, Texas.

Long-acting injectable HIV treatment given every 2 months was safe, well tolerated, and strongly preferred by adolescents in a recent study. Maternal influenza and TDaP vaccination during pregnancy ...

The latest update to the HEEADSSS psychosocial interview for adolescents includes new questions on electronic media use in addition to its time-tested strategies for identifying the critical stressors ...

Finding an acceptable alternative to breast milk has proved to be a complicated quest that continues today. Finding an acceptable alternative to breast milk has proved to be a complicated quest that ...

Lifestyle medicine and mental health management in pediatric primary care promote positive health and holistic well-being. Mental health challenges present differently at each developmental stage.

Despite the growing involvement of fathers in their children’s lives, there persists a lack of focus on fathers in pediatric care. Updated guidelines can help pediatricians to better engage fathers in ...

An overview of commercially available infant cardiorespiratory monitors and pulse oximeters in the home. Over the past decade, there has been an emergence of commercially available home devices to ...

Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know. Ultimately, there is a paucity of safety data for several ...

The federal agency has assigned a target action date of January 31, 2026, for a decision. The FDA has accepted a new drug application (NDA) for epinephrine sublingual film (Anaphylm; Aquestive ...

FDA approves Kygevvi, the first therapy for thymidine kinase 2 deficiency, a rare mitochondrial disease marked by muscle weakness and early death. The US Food and Drug Administration (FDA) has ...